← Eichor
Study identifier: NCT06936943 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

ONO-4538 Study in Patients With Richter's Transformation

Condition: Richter's Transformation  ·  Sponsor: Ono Pharmaceutical Co., Ltd.

PhasePhase 2
Planned participants14
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

Investigate the efficacy and safety of ONO-4538 in patients with Richter's transformation

This description comes directly from the study's public registry record.

Talk to the study team

North America Clinical Trial Support Desk  ·  +18665877745(Toll-Free)  ·  clinical_trial@ono-pharma.com

International Clinical Trial Support Desk  ·  +17162141777(Standard)  ·  clinical_trial@ono-pharma.com

Always discuss trial participation with your own doctor first.

Locations (10)

Aichi Cancer CenterNagoya, Aichi-ken, JapanRecruiting
Kyusyu University HospitalFukuoka, Fukuoka, JapanRecruiting
Hiroshima Red Cross Hospital & Atomic-bomb Survivors HospitalHiroshima, Hiroshima, JapanRecruiting
Hokkaido University HospitalSapporo, Hokkaido, JapanRecruiting
Kyoto University HospitalKyoto, Kyoto, JapanRecruiting
Tohoku University HospitalSendai, Miyagi, JapanRecruiting
Niigata University Medical & Dental HospitalNiigata, Niigata, JapanRecruiting
Kindai University HospitalŌsaka-sayama, Osaka, JapanRecruiting
Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome HospitalBunkyō-Ku, Tokyo, JapanRecruiting
National Cancer Center HospitalChuo Ku, Tokyo, JapanRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06936943